Association Between DPP-4 Inhibitors and Events of Colorectal and Liver Cancers in Patients With Diabetes Receiving Second-Line Agents: A Nested Case-Control Study

ObjectivePlasma dipeptidyl peptidase-4 (DPP4) levels were significantly lower in patients with colorectal and liver cancers, and animal studies also showed DPP4 inhibitors (DPP4is) have procarcinogenic effects in colorectal cancer. Until now, whether DPP4is therapy affects the progression of liver c...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Chu-Lin Chou, Shu-Hui Juan, Ching-Hao Li, Hsi-Hsien Chen, Chih-Chin Kao, Li-Ying Chen, Li-Nien Chien, Te-Chao Fang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2022-05-01
Cyfres:Frontiers in Oncology
Pynciau:
DPP-4 inhibitors
colorectal cancer
liver cancer
second-line agents
type 2 diabetes mellitus
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fonc.2022.840142/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg